Search Within

Alan Loh Ho

  1. "2024"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (10)
  3. Editorial (1)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (25)
  2. Head and Neck Service (25)
  3. Solid Tumor Oncology Division (25)
  4. Weinberg Fellows (11)
  5. Department of Pathology and Laboratory Medicine (9)
  6. Division of Subspecialty Medicine (8)

More Groups

People
  1. David Pfister (11)
  2. Eric Sherman (10)
  3. Lara Dunn (10)
  4. Winston Wong (8)
  5. Kin Wai Hung (7)
  6. Loren Michel (6)

More People

Years
  1. 2024 (25)
Publications
  1. Annals of Oncology (6)
  2. Journal of Clinical Oncology (5)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Oral Oncology (2)
  5. Cancer (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Oxford University Press (7)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (5)
  4. Springer (2)
  5. American Association for Cancer Research (1)
  6. Harborside Press (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
    Meeting Abstract

    Wong, W.; Sherman, E. J.; Kriplani, A.; Michel, L.; Zhi, I.; Hung, T. K. W.; Dunn, L.; Grewal, R. K.; Krishnamoorthy, G.; Ostrovnaya, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Cracchiolo, J.; Ho, A. L.; Sherman, E. J.; Ganly, I.; Ghossein, R.; Cohen, M.; Wong, W.; Desilets, A.; Michel, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Meeting Abstract

    Wong, W.; Adkins, D. R.; Misleh, J. G.; Lorch, J.; Grewal, J. S.; Russell, J.; Cetnar, J.; Ho, A. L.; Chen, K.; Aysola, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC
    Meeting Abstract

    Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II randomized trial of chemotherapy followed by surgery and PORT versus surgery and PORT for organ preservation of T3 and T4a (selected T4b) sinonasal squamous cell carcinoma (SNC): A trial of the ECOG-ACRIN cancer research group (EA3163)
    Meeting Abstract

    Saba, N. F.; Flamand, Y.; Lin, D. T.; Chung, C. H.; McDonald, M. W.; Flampouri, S.; Khan, S. A.; Snyderman, C. H.; Hanna, E.; El-Sayed, Y. H.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Long-term results of external beam radiation therapy (RT) with or without concurrent chemotherapy in loco regionally advanced or recurrent differentiated thyroid cancer (DTC)
    Meeting Abstract

    Choi, J.; Sherman, E.; Youssef, I.; Kang, J. J.; Zakeri, K.; Yu, Y.; Chen, L.; Shamseddine, A.; McBride, S.; Riaz, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of regorafenib in recurrent/metastatic adenoid cystic carcinoma
    Journal Article

    Desilets, A.; Vos, J. L.; Katabi, N.; Kuo, F.; Nadeem, Z.; Linxweiler, M.; Ostrovnaya, I.; Baxi, S.; Dunn, L. A.; Sherman, E. J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Targeted RNA sequencing of head and neck adenoid cystic carcinoma reveals SEC16A::NOTCH1 fusion and MET exon 14 skipping as potentially actionable alterations
    Journal Article

    Chu, Y. H.; Xu, B.; Sukhadia, P.; Mohanty, A. S.; DiNapoli, S. E.; Ho, A. L.; Katabi, N.; Dogan, S.
    Head and Neck Pathology (2024)

    Fulltext@MSK | Save
  • Performance of retrieval-augmented large language models to recommend head and neck cancer clinical trials
    Research Letter

    Hung, T. K. W.; Kuperman, G. J.; Sherman, E. J.; Ho, A. L.; Weng, C.; Pfister, D. G.; Mao, J. J.
    Journal of Medical Internet Research (2024)

    Fulltext@MSK | Save